|
|
||||||||
Nuclear Medicine |
1 From the Departments of Oncological Diagnostics and Therapy (A.D.S., L.G.S., G.I., G.K., G.v.K.) and Radiochemistry and Radiopharmacology (F.O.), Medical PET-Group, Biological Imaging, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany; the Department of Internal Medicine IV, University of Heidelberg, Germany (F.G.); and the Department of Nuclear Medicine, Dong-A University, Pusan, South Korea (D.K.K.). From the 1997 RSNA scientific assembly. Received February 11, 1998; revision requested April 15; revision received September 21; accepted December 15. Address reprint requests to A.D.S.
PURPOSE: To evaluate the carbon 11 ethanol kinetics with positron emission tomography after intratumoral injection of the tracer and assess its redistribution and dilution in patients who have hepatocellular carcinomas and who were scheduled for treatment with percutaneous ethanol injection.
MATERIALS AND METHODS: The study included eight patients with hepatocellular carcinomas. 11C ethanol was administered via a puncture needle positioned with ultrasonographic guidance. Parametric images based on the Fourier transformation were created for further analysis of the local distribution patterns of the tracer. The ratio of the 45-minute postinjection standardized uptake value to the 5-minute postinjection standardized uptake value was used for the evaluation of ethanol dilution.
RESULTS: Five of eight tumors demonstrated almost constant uptake values after the initial distribution phase. In contrast, a rapid elimination of the 11C ethanol from the tumor was documented in three of eight tumors. The 45 minuteto5 minute ratio was 0.180.67 (median value, 0.56) in the tumors. The time-activity curves of the normal liver parenchyma increased slowly but steadily with time owing to a low ethanol elimination from the tumor. Fourier transformation demonstrated inhomogeneous parts on the amplitude images in seven of eight tumors and random redistribution on the phase images in six of eight tumors.
CONCLUSION: Inhomogeneous drug distribution and drug dilution in the target area are likely to be the major limiting parameters for therapy response.
Index terms: Alcohol, 761.12163 Liver neoplasms, chemotherapeutic infusion, 761.12168, 761.323 Liver neoplasms, radionuclide studies, 761.12163, 761.323 Liver neoplasms, therapy, 761.12163, 761.323
This article has been cited by other articles:
![]() |
L. Arrive, O. Rosmorduc, H. Dahan, L. Fartoux, L. Monnier-Cholley, M. Lewin, R. Poupon, and J.-M. Tubiana Percutaneous Acetic Acid Injection for Hepatocellular Carcinoma: Using CT Fluoroscopy to Evaluate Distribution of Acetic Acid Mixed with an Iodinated Contrast Agent Am. J. Roentgenol., January 1, 2003; 180(1): 159 - 162. [Abstract] [Full Text] [PDF] |
||||